potassium hydroxide

Small moleculeexperimental

Clinical trial activity

5 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
2
Phase 4
0

Earliest trial started Mar 1, 2010 (NCT01348386)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

[K+].[OH-]
Mol. weight
56.1 g/mol
Chirality
Achiral Molecule
Inorganic
Yes
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • hydroxide potassium
  • potassium hydroxide
  • potassium hydroxide
  • potassium hydroxide
  • potassium hydroxide
  • potassium hydroxide, 39k-labeled
  • potassium hydroxide, 41k-labeled
  • potassium hydroxide monohydrate
  • potassium hydroxide tetrahydrate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05895071Phase 1Nov 1, 2022Government of Pakistan
NCT05897112Phase 1Nov 1, 2022Government of Pakistan
NCT05198180Phase 3Feb 28, 2022Sohag University
NCT04476186N/AJun 15, 2020Assiut University, Cairo University
NCT01348386Phase 2/Phase 3 (Phase 3)Mar 1, 2010Jordi Gol i Gurina Foundation
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of PakistanGovernment2212022
Assiut UniversityAcademic/Hospital1112020
Cairo UniversityAcademic/Hospital1012020
Jordi Gol i Gurina FoundationAcademic/Hospital1112010
Sohag UniversityAcademic/Hospital1112022
5 organizations
Page 1 / 1